403 related articles for article (PubMed ID: 33599882)
41. The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.
Ly KI; Gerstner ER
Curr Treat Options Oncol; 2018 Jun; 19(8):40. PubMed ID: 29931476
[TBL] [Abstract][Full Text] [Related]
42. Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients.
Lohmann P; Werner JM; Shah NJ; Fink GR; Langen KJ; Galldiks N
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30699942
[TBL] [Abstract][Full Text] [Related]
43. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
Kim ES; Satter M; Reed M; Fadell R; Kardan A
Neuroradiol J; 2016 Jun; 29(3):193-7. PubMed ID: 27122050
[TBL] [Abstract][Full Text] [Related]
44. Concurrent functional and metabolic assessment of brain tumors using hybrid PET/MR imaging.
Sacconi B; Raad RA; Lee J; Fine H; Kondziolka D; Golfinos JG; Babb JS; Jain R
J Neurooncol; 2016 Apr; 127(2):287-93. PubMed ID: 26729270
[TBL] [Abstract][Full Text] [Related]
45. Advanced MR imaging in hemispheric low-grade gliomas before surgery; the indications and limits in the pediatric age.
Gaudino S; Russo R; Verdolotti T; Caulo M; Colosimo C
Childs Nerv Syst; 2016 Oct; 32(10):1813-22. PubMed ID: 27659824
[TBL] [Abstract][Full Text] [Related]
46. Static
Song S; Wang L; Yang H; Shan Y; Cheng Y; Xu L; Dong C; Zhao G; Lu J
Eur Radiol; 2021 Jun; 31(6):4087-4096. PubMed ID: 33211141
[TBL] [Abstract][Full Text] [Related]
47. Impact of
Brendle C; Maier C; Bender B; Schittenhelm J; Paulsen F; Renovanz M; Roder C; Castaneda-Vega S; Tabatabai G; Ernemann U; Fougère C
J Nucl Med; 2022 Apr; 63(4):522-527. PubMed ID: 34353870
[TBL] [Abstract][Full Text] [Related]
48. (18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Bolcaen J; Descamps B; Deblaere K; Boterberg T; De Vos Pharm F; Kalala JP; Van den Broecke C; Decrock E; Leybaert L; Vanhove C; Goethals I
Nucl Med Biol; 2015 Jan; 42(1):38-45. PubMed ID: 25218024
[TBL] [Abstract][Full Text] [Related]
49. Correlation of Dynamic O-(2-[
Lohmann P; Piroth MD; Sellhaus B; Weis J; Geisler S; Oros-Peusquens AM; Mohlberg H; Amunts K; Shah NJ; Galldiks N; Langen KJ
World Neurosurg; 2018 Nov; 119():e653-e660. PubMed ID: 30077752
[TBL] [Abstract][Full Text] [Related]
50. Combination of MRI and dynamic FET PET for initial glioma grading.
Dunet V; Maeder P; Nicod-Lalonde M; Lhermitte B; Pollo C; Bloch J; Stupp R; Meuli R; Prior JO
Nuklearmedizin; 2014 Aug; 53(4):155-61. PubMed ID: 24737132
[TBL] [Abstract][Full Text] [Related]
51. [Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].
Galldiks N; Langen KJ
Fortschr Neurol Psychiatr; 2012 Jan; 80(1):17-23. PubMed ID: 22161228
[TBL] [Abstract][Full Text] [Related]
52. Advanced MR Techniques for Preoperative Glioma Characterization: Part 1.
Hirschler L; Sollmann N; Schmitz-Abecassis B; Pinto J; Arzanforoosh F; Barkhof F; Booth T; Calvo-Imirizaldu M; Cassia G; Chmelik M; Clement P; Ercan E; Fernández-Seara MA; Furtner J; Fuster-Garcia E; Grech-Sollars M; Guven NT; Hatay GH; Karami G; Keil VC; Kim M; Koekkoek JAF; Kukran S; Mancini L; Nechifor RE; Özcan A; Ozturk-Isik E; Piskin S; Schmainda K; Svensson SF; Tseng CH; Unnikrishnan S; Vos F; Warnert E; Zhao MY; Jancalek R; Nunes T; Emblem KE; Smits M; Petr J; Hangel G
J Magn Reson Imaging; 2023 Jun; 57(6):1655-1675. PubMed ID: 36866773
[TBL] [Abstract][Full Text] [Related]
53. Advanced MR Techniques for Preoperative Glioma Characterization: Part 2.
Hangel G; Schmitz-Abecassis B; Sollmann N; Pinto J; Arzanforoosh F; Barkhof F; Booth T; Calvo-Imirizaldu M; Cassia G; Chmelik M; Clement P; Ercan E; Fernández-Seara MA; Furtner J; Fuster-Garcia E; Grech-Sollars M; Guven NT; Hatay GH; Karami G; Keil VC; Kim M; Koekkoek JAF; Kukran S; Mancini L; Nechifor RE; Özcan A; Ozturk-Isik E; Piskin S; Schmainda KM; Svensson SF; Tseng CH; Unnikrishnan S; Vos F; Warnert E; Zhao MY; Jancalek R; Nunes T; Hirschler L; Smits M; Petr J; Emblem KE
J Magn Reson Imaging; 2023 Jun; 57(6):1676-1695. PubMed ID: 36912262
[TBL] [Abstract][Full Text] [Related]
54. [Neuroimaging in brain tumors].
Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
[TBL] [Abstract][Full Text] [Related]
55. Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.
Kocher M; Ruge MI; Galldiks N; Lohmann P
Strahlenther Onkol; 2020 Oct; 196(10):856-867. PubMed ID: 32394100
[TBL] [Abstract][Full Text] [Related]
56. Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI.
Werner JM; Stoffels G; Lichtenstein T; Borggrefe J; Lohmann P; Ceccon G; Shah NJ; Fink GR; Langen KJ; Kabbasch C; Galldiks N
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1889-1901. PubMed ID: 31203420
[TBL] [Abstract][Full Text] [Related]
57. Use of multimodality imaging, histology, and treatment feasibility to characterize a transgenic
Jackson LR; Masi MR; Selman BM; Sandusky GE; Zarrinmayeh H; Das SK; Maharjan S; Wang N; Zheng QH; Pollok KE; Snyder SE; Sun PZ; Hutchins GD; Butch ER; Veronesi MC
Front Oncol; 2022; 12():939260. PubMed ID: 36483050
[TBL] [Abstract][Full Text] [Related]
58. Spatial Relationship of Glioma Volume Derived from
Mauler J; Maudsley AA; Langen KJ; Nikoubashman O; Stoffels G; Sheriff S; Lohmann P; Filss C; Galldiks N; Kops ER; Shah NJ
J Nucl Med; 2018 Apr; 59(4):603-609. PubMed ID: 28848036
[TBL] [Abstract][Full Text] [Related]
59. Multiparametric Framework Magnetic Resonance Imaging Assessment of Subtypes of Intracranial Germ Cell Tumors Using Susceptibility Weighted Imaging, Diffusion-Weighted Imaging, and Dynamic Susceptibility-Contrast Perfusion-Weighted Imaging Combined With Conventional Magnetic Resonance Imaging.
Li Y; Wang P; Zhang J; Li J; Chen L; Qiu X
J Magn Reson Imaging; 2022 Oct; 56(4):1232-1242. PubMed ID: 35278008
[TBL] [Abstract][Full Text] [Related]
60. The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
Heinzel A; Müller D; Langen KJ; Blaum M; Verburg FA; Mottaghy FM; Galldiks N
J Nucl Med; 2013 Aug; 54(8):1217-22. PubMed ID: 23785172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
